KRAS-mutant Colon Cancer Cells Respond to Combined Treatment of ABT263 and Axitinib
Bioscience Reports - Netherlands
doi 10.1042/bsr20181786
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Portland Press Ltd.
Available in full text
March 1, 2019
Portland Press Ltd.